Sound exposures and hearing thresholds of symphony orchestra musicians.
To assess the risk of noise-induced hearing loss among musicians in the Chicago Symphony Orchestra, personal dosimeters set to the 3-dB exchange rate were used to obtain 68 noise exposure measurements during rehearsals and concerts. The musicians' Leq values ranged from 79-99 dB A-weighted sound pressure level [dB(A)], with a mean of 89.9 dB(A). Based on 15 h of on-the-job exposure per week, the corresponding 8-h daily Leq (excluding off-the-job practice and playing) ranged from 75-95 dB(A) with a mean of 85.5 dB(A). Mean hearing threshold levels (HTLs) for 59 musicians were better than those for an unscreened nonindustral noise-exposed population (NINEP), and only slightly worse than the 0.50 fractile data for the ISO 7029 (1984) screened presbycusis population. However, 52.5% of individual musicians showed notched audiograms consistent with noise-induced hearing damage. Violinists and violists showed significantly poorer thresholds at 3-6 kHz in the left ear than in the right ear, consistent with the left ear's greater exposure from their instruments. After HTLs were corrected for age and sex, HTLs were found to be significantly better for both ears of musicians playing bass, cello, harp, or piano and for the right ears of violinists and violists than for their left ears or for both ears of other musicians. For 32 musicians for whom both HTLs and Leq were obtained, HTLs at 3-6 kHz were found to be correlated with the Leq measured.
Environmental Noise Consultants, Inc., Raleigh, North Carolina 27622-0698.
J D
JD
Royster
L H
LH
Royster
M C
MC
Killion
D000162:Acoustics; D000328:Adult; D000368:Aged; D001299:Audiometry; D001309:Auditory Threshold; D005260:Female; D006317:Hearing Loss, Noise-Induced / Q000453:epidemiology* / Q000209:etiology; D006801:Humans; D016018:Least-Squares Analysis; D008297:Male; D008875:Middle Aged; D009146:Music; D009784:Occupational Diseases / Q000453:epidemiology* / Q000209:etiology; D012307:Risk Factors; D013016:Sound / Q000009:adverse effects